medigraphic.com
Instituto Nacional de Salud Pública

2007, Número 1

Siguiente >>

salud publica mex 2007; 49 (1)


Cartas al editor

Camarillo-Romero MS

Idioma: Ingles.
Referencias bibliográficas: 37
Paginas: 1-2
Archivo PDF: 62.59 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Solórzano-Santos F, Miranda Novales G.

  2. Resistencia de las bacterias respiratorias y entéricas a antibióticos. Salud Publica Mex 1998;6:510-516.

  3. Sistema Nacional de Evaluación - Tercera vigilancia de los progresos en la aplicación de estrategias de salud para todos en el año 2000,SPT/2000- México, DF: INEGI/DGEIE, 1994.

  4. Avila MM, Carballal G, Rovaletti H, Ebekian B, Cusminsky MM, Weissenbacher M. Viral etiology in acute lower respiratory infections in children from a closed community. Am Rev Resp Dis 1989;140:634-637.

  5. Fenddrick AM, Saint S, Brook I, Jacobs MR,Pelton S, Sethi S. Diagnosis and treatment ofupper respiratory tract infections in the primarycare setting. Clin Ther 2001;10:1683-1706.

  6. Lavoie F, Blais L, Castilloux AM, Saclera A, LeLorier J. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB). Can J Clin Pharmacol 2005;2:e212-e217.

  7. Stratchounski LS, Andreeva IV, Ratchina SA, Galkin DV, Petrotchenkova Na, Demin AA, et al. The inventory of antibiotics in Russian home medicine cabinets. HYPERLINK “javascript:AL_get(this, ‘jour’, ‘Clin Infect Dis.’);” Clin Infect Dis 2003;37(4):498-505.

  8. Doern GV, Jones RN, Pfaller MA, Kugler K. and The sentry Participants Group. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997) Antimicrob. Agents Chemother 1999;2:385-389.

  9. Gunnarsson RK, Holm SE, Söderström M. The prevalence of potentially pathogenic bacteria in nasopharyngeal samples from individuals with a long standing cough-clinical value of nasopharyngeal sample. Family Practice 2000;2:150-155.

  10. Murphy TF. Branhamella catarrhalis: epidemiology, surface antigenic structure, and inmune response. Microbiol Rev 1996;2:267-279.

  11. Carr B, Walsh JB, Coakley D, Mulvihill E, Keane C. Prospective hospital study of community acquired lower respiratory tract infection in the elderly. Respiratory Medicine1991;85:185-187.

  12. García Rodríguez JA, Fresnadillo Martinez MJ. Dynamics of nasopharyngeal colonization by potencial respiratory pathogens. J Antimicrob Chemother 2002;(Suppl 2):S59-S73.

  13. Chi DH, Hendley JO, French P, Arango P, Hayden FG, Winther B. Nasopharingeal reservoir of Bacterial Otitis media and sinusitis pathogens in adults during wellness and viral respiratory illness. Am J Rhinol 2003;4:209-214.

  14. Leaños-Miranda B, Miranda-Novales MG, Solórzano-Santos F, Ortiz-Ocampo L, Guiscafré- Gallardo H. Prevalencia de colonización por Moraxella catarrhalis en portadores asintomáticos menores de seis años. Salud Publica Mex 2002;43:27-31.

  15. Hol C, Van Dijke EE, Verduin CM, Verhoef J, Van Dijk H. Experimental evidence for Moraxella –induced penicillin neutralization in pneumococcal pneumonia. J Infect Dis 1994;170:1613-1616.

  16. Schmitz FJ, Beeck A, Perdikouli M, Boos M, Mayer S, Scheuring S, et al. Production of BRO lactamases and resistance to complement in European Moraxella catarrhalis isolates J Clin Microbiol 2002;4:1546-1548.

  17. Andrade MA, Hoberman A, Glustein J, Paradise JL, Wakd ER. Acute otitis media in children with bronchitis. Pediatrics 1998;101 (4 Pt 1):617-619.

  18. Gross-Schulman S, Dassey D, Mascola l, Anaya C. Community-acquired methicilinnresistant Staphylococcus aureus. JAMA 1998;280:421-422.

  19. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections and bronchitis. JAMA 1998;279:875-877.

  20. Solórzano-Santos F, Miranda Novales G. Resistencia de las bacterias respiratorias y entéricas a antibióticos. Salud Publica Mex 1998;6:510-516.

  21. Sistema Nacional de Evaluación-Tercera vigilancia de los progresos en la aplicación de estrategias de salud para todos en el año 2000,SPT/2000-México, DF: INEGI/DGEIE, 1994.

  22. Avila MM, Carballal G, Rovaletti H, Ebekian B, Cusminsky MM, Weissenbacher M. Viral etiology in acute lower respiratory infections in children from a closed community. Am Rev Resp Dis 1989;140:634-637.

  23. Fenddrick AM, Saint S, Brook I, Jacobs MR,Pelton S, Sethi S. Diagnosis and treatment ofupper respiratory tract infections in the primarycare setting. Clin Ther 2001;10:1683-1706.

  24. Lavoie F, Blais L, Castilloux AM, Saclera A, LeLorier J. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB). Can J Clin Pharmacol 2005;2:e212-e217.

  25. Stratchounski LS, Andreeva IV, Ratchina SA, Galkin DV, Petrotchenkova Na, Demin AA, et al. The inventory of antibiotics in Russian home medicine cabinets. HYPERLINK “javascript:AL_get(this, ‘jour’, ‘Clin Infect Dis.’);” Clin Infect Dis 2003;37(4):498-505.

  26. Doern GV, Jones RN, Pfaller MA, Kugler K. and The sentry Participants Group. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997) Antimicrob. Agents Chemother 1999;2:385-389.

  27. Gunnarsson RK, Holm SE, Söderström M. The prevalence of potentially pathogenic bacteria in nasopharyngeal samples from individuals with a long standing cough-clinical value of nasopharyngeal sample. Family Practice 2000;2:150-155.

  28. Murphy TF. Branhamella catarrhalis: epidemiology, surface antigenic structure, and inmune response. Microbiol Rev 1996;2:267-279.

  29. Carr B, Walsh JB, Coakley D, Mulvihill E, Keane C. Prospective hospital study of community acquired lower respiratory tract infection in the elderly. Respiratory Medicine1991;85:185-187.

  30. García Rodríguez JA, Fresnadillo Martinez MJ. Dynamics of nasopharyngeal colonization by potencial respiratory pathogens. J Antimicrob Chemother 2002;(Suppl 2):S59-S73.

  31. Chi DH, Hendley JO, French P, Arango P, Hayden FG, Winther B. Nasopharingeal reservoir of Bacterial Otitis media and sinusitis pathogens in adults during wellness and viral respiratory illness. Am J Rhinol 2003;4:209-214.

  32. Leaños-Miranda B, Miranda-Novales MG, Solórzano-Santos F, Ortiz-Ocampo L, Guiscafré- Gallardo H. Prevalencia de colonización por Moraxella catarrhalis en portadores asintomáticos menores de seis años. Salud Publica Mex 2002;43:27-31.

  33. Hol C, Van Dijke EE, Verduin CM, Verhoef J, Van Dijk H. Experimental evidence for Moraxella–induced penicillin neutralization in pneumococcal pneumonia. J Infect Dis 1994;170:1613-1616.

  34. Schmitz FJ, Beeck A, Perdikouli M, Boos M, Mayer S, Scheuring S, et al. Production of BRO lactamases and resistance to complement in European Moraxella catarrhalis isolates J Clin Microbiol 2002;4:1546-1548.

  35. Andrade MA, Hoberman A, Glustein J, Paradise JL, Wakd ER. Acute otitis media in children with bronchitis. Pediatrics 1998;101 (4 Pt 1):617-619.

  36. Gross-Schulman S, Dassey D, Mascola l, Anaya C. Community-acquired methicilinnresistant Staphylococcus aureus. JAMA 1998;280:421-422.

  37. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections and bronchitis. JAMA 1998;279:875-877.




2020     |     www.medigraphic.com